Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation

Blood

Volumn 88, Issue 9, 1996, Pages 3621-3625

  Euler, Hans H ^b   Marmont, Alberto M ^b   Bacigalupo, Andrea ^b   Fastenrath, Sven ^b   Dreger, Peter ^b   Hoffknecht, Matthias ^b   Zander, Axel R ^b   Schalke, Berthold ^b   Hahn, Uwe ^b   Haas, Rainer ^b   Schmitz, Norbert ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; MELPHALAN;

ADULT; ARTICLE; ATOPIC DERMATITIS; AUTOIMMUNITY; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; HASHIMOTO DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STEM CELL TRANSPLANTATION; SURGERY; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 10344262612     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3621.bloodjournal8893621     Document Type: Article

References (33)

1. Brooks PM, Atkinson K, Hamilton PJ: Stem cell transplantation for autoimmune diseases. J Rheumatol 22:1809, 1995
2. Burt RK, Burns W, Hess A: Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 16:1, 1995
3. Marmont AM, van Bekkum DW: Stem cell transplantation for severe autoimmune diseases: New proposals but still unanswered questions. Bone Marrow Transplant 16:497, 1995
4. Marmont AM: Immune ablation followed by stem cell rescue: A new radical approach to the treatment of severe autoimmune diseases. Forum Trends Exp Clin Med 5:24, 1995
5. Tyndall A, Gratwohl A: Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis 55:149, 1996
6. Euler HH, Fastenrath S, Dreger P, Schmitz N, Marmont AM: Bone marrow transplantation. A new treatment option in severe SLE? Aktuelle Rheumatol 21:114, 1996
7. Marmont A, Tyndall A, Gratwohl A, Vischer T: Haemopoietic precursor-cell transplants for autoimmune diseases. Lancet 345:978, 1995
8. van Bekkum DW: BMT in experimental autoimmune diseases. Bone Marrow Transplant 11:183, 1993
9. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaertz MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K: Filgrastim-mobilized peripheral blood progenitor cell transplantation in comparison with autologous bone marrow transplantation: Results of a randomized phase III trial in lymphoma patients. Lancet 347:353, 1996
10. Fastenrath S, Dreger P, Schmitz N, Euler HH: Autologous unpurged bone marrow transplantation in a patient with lymphoma and SLE: Short term recurrence of antinuclear antibodies. Arthritis Rheum 38:S303, 1995 (abstr, suppl)
11. Dreger P, Marquardt P, Haferlach T, Jacobs S, Muelverstedt T, Eckstein V, Suttorp M, Loeffler H, Muller-Ruchholtz W, Schmitz N: Effective mobilisation of peripheral blood progenitor cells with 'Dexa-BEAM' and G-CSF: Timing of harvesting and composition of the leukapheresis product. Br J Cancer 68:950, 1993
12. Ikuta K, Uchida N, Friedman J, Weissman IL: Lymphocyte development from stem cells. Annu Rev Immunol 10:759, 1992
13. Relink AG, Reininger L, Oka Y, Kalberer CP, Winkler TH, Melchers F: Repopulation of SCID mice with long-term in vitro proliferating pre-B-cell lines from normal and autoimmune disease-prone mice. Res Immunol 145:353, 1994
14. Horstmann M, Stockschlader M, Kruger W, Hoffknecht M, Betker R, Kabisch H, Zander A: Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results. Ann Hematol 71:77, 1995
15. Blank M, Krause I, Lanir N, Vardi P, Gilburd B, Tincani A, Tomer Y, Shoenfeld Y: Transfer of experimental antiphospholipid syndrome by bone marrow cell transplantation. The importance of the T cell. Arthritis Rheum 38:115, 1995
16. Lampeler EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341:1243, 1993
17. Lowenthal RM, Cohen ML, Atkinson K, Biggs JC: Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 20:137, 1993
18. Ikehara S, Inaba M, Yasumizu R, Nagata N, Toki J, Hisha H, Sugiura K, Oyaizu N, Kawamura M, Than S: Autoimmune diseases as stem cell disorders. Tohoku J Exp Med 173:141, 1994
19. Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S: Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation. Clin Exp Immunol 100:111, 1995
20. Levite M, Zinger H, Zisman E, Reisner Y, Mozes E: Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Cell Immunol 162:138, 1995
21. Theofilopoulos AN: The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today 16:150, 1995
22. Atkinson JP: Some thoughts on autoimmunity. Arthritis Rheum 38:301, 1995
23. Boumpas DT, Austin HA III, Fessier BJ, Balow JE. Klippel JH, Lockshin MD: Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 122:940, 1995
24. Jarvinen P, Aho K: Twin studies in rheumatic diseases. Semin Arthritis Rheum 24:19, 1994
25. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 37:1784, 1994
26. Brodsky RA, Sensenbrenner LL, Jones RJ: Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 87:491, 1996
27. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28, 1994
28. Dreger P, Viehmann K, Steinmann J, Eckstein V, Mueller-Ruchholtz W, Loeffler H, Schmitz N: G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems of CAMPATH-1. Exp Hematol 23:147, 1995
29. Gribben JG, Nadler LM: Antibody-mediated purging, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation, Boston, MA, Blackwell Scientific, 1995, p 149
30. Salzman D, Tami J, Jackson C, Castro J, Boldt D, Freytes C, Berenson R, LeMaistre CF: Clinical remission of myasthenia gravis in a patient after high dose therapy and autologous transplantation with CD34+ stem cells. Blood 84:206a, 1994 (abstr, suppl 1)
31. Fassas A, Anagnostopoulos A, Kazis A, Sakellari I, Kapinas K, Kaloyannides P: Peripheral blood progenitor cell transplantation for treatment of multiple sclerosis. Preliminary report. Bone Marrow Transplant 17:69, 1996 (abstr, suppl 1)
32. Snowden JA, Habbah EE, O'Donnell J, Patton WN, Hart DNJ: Resolution of longstanding systemic lupus erythematosus after autologous bone marrow transplantation for non-Hodgkins lymphoma. A case report. Bone Marrow Transplant 17:70, 1996 (abstr, suppl 1)
33. Stiff PJ: Cryopreservation of hematopoietic stem cells, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation, Boston, MA, Blackwell Scientific, 1994, p 299